<DOC>
	<DOCNO>NCT00029640</DOCNO>
	<brief_summary>This study seek learn brain function adolescent depression determine whether add lithium carbonate antidepressant medication reduce depression child adolescent . Functional magnetic resonance imaging ( fMRI ) magnetic resonance spectroscopy ( MRS ) examine brain chemistry function .</brief_summary>
	<brief_title>The Treatment Children Adolescents With Treatment-Resistant Depression</brief_title>
	<detailed_description>The participant may may take selective serotonin reuptake inhibitor ( SSRI ) ( paroxetine ( Paxil ) , sertraline ( Zoloft ) fluoxetine ( Prozac ) ) treat depression . The participant parent interview individually together question child 's general mood , degree nervousness , behavior family member . Children adolescents physical examination , blood test , intelligence memory evaluation . Tests include standardized question task involve look picture , remember thing , test reaction time , make simple choice . Participants spend time , mock MRI scanner , become comfortable procedure . Participants parent meet weekly 2 week psychologist psychiatrist session . Those remain depressed two session begin study medication . Those currently take SSRI offer paroxetine . Those already take SSRI randomly assign receive either lithium placebo ( non-active pill ) addition SSRI . Treatment continue 8 week . During time , participant parent meet doctor week complete write oral evaluation . Blood drawn medication begin end 8-week treatment . Participants additional blood take 1 week medication help decide whether dose adjustment need . Additional blood test might need later ensure dose correct . Those improve 8 week continue treatment NIH responsibility care assume outside physician . Program staff help facilitating referral physician monitor medication child leave study .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Treatment-Resistant</mesh_term>
	<criteria>INCLUSION CRITERIA : All subject Age : 9 17 . Consent : give consent/assent . IQ : All subject IQ great 70 . Severity Criterion : CDRS great 39 . Impairment : All subject CGAS less 60 . SUBJECTS WITH A RESISTANT MDD : Diagnosis : Current Diagnosis Major Depression . Treatment Resistant : At least sixweeks continual use SSRI , last two high dose research team ; CGIS great 2 confirm observation additional two week ( least 8weeks total duration ) . MEDICATIONFREE MDD SUBJECTS : Diagnosis : Current Diagnosis Major Depression Clinical Impairment : CGAS le 60 . MedicationFree : No psychotropic medication two month period ; depress less 6 month . EXCLUSION CRITERIA : Any medical condition increase risk SSRI lithium treatment MRI exam . This include screen standard MRI scanning contraindication metallic implant pacemaker . Pregnancy . Current use psychoactive substance beyond ab SSRI ; current suicidal ideation ; current diagnosis attention deficit hyperactivity disorder ( ADHD ) sufficient severity require pharmacotherapy . Current diagnosis : Tourette 's Disorder , OCD , posttraumatic stress disorder , conduct disorder . Past current history mania , psychosis , pervasive developmental disorder . LongTerm SSRI Treatment : Subjects receive SSRI medication 12 wks long upon entry observational phase study eligible participation .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2004</verification_date>
	<keyword>MRI</keyword>
	<keyword>MRS</keyword>
	<keyword>SSRI</keyword>
	<keyword>Children</keyword>
	<keyword>Depression</keyword>
	<keyword>Augmentation</keyword>
	<keyword>Magnetic Resonance Imaging</keyword>
	<keyword>Major Depression</keyword>
	<keyword>MDD</keyword>
</DOC>